The Food and Drug Administration (FDA) has approved Khindivi ™ (hydrocortisone) oral solution as a replacement therapy in ...

The Obesity Society, along with several other organizations, jointly released a clinical advisory on nutritional priorities ...

Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and ...

The House of Mouth, Australia’s leading provider of professional-grade teeth whitening and oral care solutions, is proud to ...

Morningstar brands and products Company Portfolio ...

VERO BEACH, Fla., March 1, 2025 /PRNewswire/ -- QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, has announced Sucraid ® (sacrosidase) Oral Solution has been shown to be ...

Penile nerve blocks, local anesthetics, various operative instruments, acetaminophen, sweet oral solutions, pacifiers, a physiologic restraining device, intrauterine sounds, and music all have ...

Liporaxel oral solution showed non-inferiority in PFS and superiority in OS compared to IV Liporaxel in advanced gastric cancer patients. The phase 3 trial involved 536 patients, with a median OS of 9 ...

Phase II preoperative pembrolizumab for MSI high or MSS/PD-L1 gastric cancer followed by surgery and adjuvant therapy with pembrolizumab (NCT03257163): Results of a multicenter study. This is an ASCO ...

The company in a stock exchange filing said The UK Medicines and Healthcare Products Regulatory Agency (UKMHRA) issued market ...